TN-001
Neuropsychiatric Disorders (e.g., MDD, PTSD)
Pre-clinicalActive
Key Facts
Indication
Neuropsychiatric Disorders (e.g., MDD, PTSD)
Phase
Pre-clinical
Status
Active
Company
About Transneural Therapeutics
Transneural Therapeutics is a private, pre-clinical stage biotech developing a pipeline of novel, rapid-acting neuroplastogens for neuropsychiatric disorders. The company leverages a seasoned leadership team with extensive CNS drug development and commercialization experience, and integrates artificial intelligence with traditional drug discovery to identify and synthesize new compounds. Its initial focus is on lead asset TN-001 and two other programs targeting major depressive disorder (MDD), PTSD, and other conditions with high unmet need.
View full company profile